載入...
Phase I Study of the Tolerability and Pharmacokinetics of Palifermin in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
The maximum tolerated dose of palifermin, a keratinocyte growth factor, in children is not known, and its pharmacokinetics in this population has not been well studied. This is a phase I study of palifermin was designed to evaluate its tolerability at doses of 40, 60, and 90 μg/kg/day in children ag...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2012
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539307/ https://ncbi.nlm.nih.gov/pubmed/22542710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.04.013 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|